DNA-PKcs associates with PLK1 and is involved in proper chromosome segregation and cytokinesis

Journal of Cellular Biochemistry

Volumn 115, Issue 6, 2014, Pages 1077-1088

  Huang, Bo ^a,b,c   Shang, Zeng Fu ^b   Li, Bing ^b   Wang, Yu ^b   Liu, Xiao Dan ^b   Zhang, Shi Meng ^b   Guan, Hua ^b   Rang, Wei Qing ^c   Hu, Jian An ^a   Zhou, Ping Kun ^b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

CYTOKINESIS; DNA DAMAGE RESPONSE; DNA PKcs; GENOMIC STABILITY; MITOTIC PROGRESSION; PLK1

Indexed keywords

DNA; POLO LIKE KINASE 1; PROTEIN KINASE C; CELL CYCLE PROTEIN; DNA DEPENDENT PROTEIN KINASE; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE;

ANAPHASE; ARTICLE; CELL CYCLE PROGRESSION; CENTROMERE; CENTROSOME; CHROMOSOME ABERRATION; CHROMOSOME SEGREGATION; CONTROLLED STUDY; CYTOKINESIS; DAUGHTER CELL; DNA DAMAGE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METAPHASE; MITOSIS; MULTINUCLEAR CELL; PRIORITY JOURNAL; PROMETAPHASE; PROPHASE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SISTER CHROMATID; CELL CYCLE; CONFOCAL MICROSCOPY; DNA REPAIR; ENZYME ACTIVE SITE; FLOW CYTOMETRY; GENETICS; HELA CELL LINE; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION; PROCEDURES; RNA INTERFERENCE; TIME LAPSE IMAGING;

CATALYTIC DOMAIN; CELL CYCLE; CELL CYCLE PROTEINS; CENTROSOME; CHROMOSOME SEGREGATION; CYTOKINESIS; DNA DAMAGE; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; FLOW CYTOMETRY; HELA CELLS; HUMANS; IMMUNOBLOTTING; KINETOCHORES; MICROSCOPY, CONFOCAL; MITOSIS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; TIME-LAPSE IMAGING;

EID: 84904740058     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24703     Document Type: Article

References (43)

1. Archambault V, Carmena M,. 2012. Polo-like kinase-activating kinases: Aurora A, Aurora B and what else ? Cell Cycle 11: 1490-1495.
2. Barr FA, Gruneberg U,. 2007. Cytokinesis: Placing and making the final cut. Cell 131: 847-860.
3. Bastos RN, Penate X, Bates M, Hammond D, Barr FA,. 2012. CYK4 inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways during cytokinesis. J Cell Biol 198: 865-880.
4. Bruinsma W, Raaijmakers JA, Medema RH,. 2012. Switching Polo-like kinase-1 on and off in time and space. Trends Biochem Sci 37: 534-542.
5. Burkard ME, Randall CL, Larochelle S, Zhang C, Shokat KM, Fisher RP, Jallepalli PV,. 2007. Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proc Natl Acad Sci USA 104: 4383-4388.
6. Ebrahimi S, Fraval H, Murray M, Saint R, Gregory SL,. 2010. Polo kinase interacts with RacGAP50C and is required to localize the cytokinesis initiation complex. J Biol Chem 285: 28667-28673.
7. Feng YB, Lin DC, Shi ZZ, Wang XC, Shen XM, Zhang Y, Du XL, Luo ML, Xu X, Han YL, Cai Y, Zhang ZQ, Zhan QM, Wang MR,. 2009. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of AT level in esophageal squamous cell carcinoma. Int J Cancer 124: 578-588.
8. Garcia-Alvarez B, de Carcer G, Ibanez S, Bragado-Nilsson E, Montoya G,. 2007. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization. Proc Natl Acad Sci USA 104: 3107-3112.
9. Glotzer M,. 2005. The molecular requirements for cytokinesis. Science 307: 1735-1739.
10. Hu CK, Coughlin M, Mitchison TJ,. 2012. Midbody assembly and its regulation during cytokinesis. Mol Biol Cell 23: 1024-1034.
11. Huang H, Fletcher L, Beeharry N, Daniel R, Kao G, Yen TJ, Muschel RJ,. 2008. Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res 68: 3724-3732.
12. Ito Y, Miyoshi E, Sasaki N, Kakudo K, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A,. 2004. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br J Cancer 90: 414-418.
13. Juan G, Traganos F, James WM, Ray JM, Roberge M, Sauve DM, Anderson H, Darzynkiewicz Z,. 1998. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32: 71-77.
14. Krause SA, Cundell MJ, Poon PP, McGhie J, Johnston GC, Price C, Gray JV,. 2012. Functional specialisation of yeast Rho1 GTP exchange factors. J Cell Sci 125: 2721-2731.
15. Lee KJ, Lin YF, Chou HY, Yajima H, Fattah KR, Lee SC, Chen BP,. 2011. Involvement of DNA-dependent protein kinase in normal cell cycle progression through mitosis. J Biol Chem 286: 12796-12802.
16. Lenart P, Petronczki M, Steegmaier M, Di Fiore B, Lipp JJ, Hoffmann M, Rettig WJ, Kraut N, Peters JM,. 2007. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr Biol 17: 304-315.
17. Li J, Wang J, Hou W, Jing Z, Tian C, Han Y, Liao J, Dong MQ, Xu X,. 2011. Phosphorylation of Ataxin-10 by polo-like kinase 1 is required for cytokinesis. Cell Cycle 10: 2946-2958.
18. Lindon C, Pines J,. 2004. Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells. J Cell Biol 164: 233-241.
19. Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX,. 2012. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC cancer 12: 519.
20. Lu LY, Yu X,. 2009. The balance of Polo-like kinase 1 in tumorigenesis. Cell Div 4: 4.
21. Ma Y, Lu H, Schwarz K, Lieber MR,. 2005. Repair of double-strand DNA breaks by the human nonhomologous DNA end joining pathway: The iterative processing model. Cell Cycle 4: 1193-1200.
22. Mundt KE, Golsteyn RM, Lane HA, Nigg EA,. 1997. On the regulation and function of human polo-like kinase 1 (PLK1): Effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 239: 377-385.
23. Neef R, Gruneberg U, Kopajtich R, Li X, Nigg EA, Sillje H, Barr FA,. 2007. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1. Nat Cell Biol 9: 436-444.
24. Otegui MS, Verbrugghe KJ, Skop AR,. 2005. Midbodies and phragmoplasts: Analogous structures involved in cytokinesis. Trends Cell Biol 15: 404-413.
25. Peng Y, Woods RG, Beamish H, Ye R, Lees-Miller SP, Lavin MF, Bedford JS,. 2005. Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM. Cancer Res 65: 1670-1677.
26. Piekny A, Werner M, Glotzer M,. 2005. Cytokinesis: Welcome to the Rho zone. Trends Cell Biol 15: 651-658.
27. Prokopenko SN, Brumby A, O'Keefe L, Prior L, He Y, Saint R, Bellen HJ,. 1999. A putative exchange factor for Rho1 GTPase is required for initiation of cytokinesis in Drosophila. Genes Dev 13: 2301-2314.
28. Randall CL, Burkard ME, Jallepalli PV,. 2007. Polo kinase and cytokinesis initiation in mammalian cells: Harnessing the awesome power of chemical genetics. Cell Cycle 6: 1713-1717.
29. Shang ZF, Huang B, Xu QZ, Zhang SM, Fan R, Liu XD, Wang Y, Zhou PK,. 2010. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 phosphorylation in response to DNA damage. Cancer Res 70: 3657-3666.
30. Shang ZF, Yu L, Li B, Tu WZ, Wang Y, Liu XD, Guan H, Huang B, Rang WQ, Zhou PK,. 2012. 4E-BP1 participates in maintaining spindle integrity and genomic stability via interacting with PLK1. Cell Cycle 11: 3463-3471.
31. Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL, Ferris DK,. 1997. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 234: 397-405.
32. Somers WG, Saint R,. 2003. A RhoGEF and Rho family GTPase-activating protein complex links the contractile ring to cortical microtubules at the onset of cytokinesis. Dev Cell 4: 29-39.
33. Sunkel CE, Glover DM,. 1988. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 89 (Pt 1): 25-38.
34. Takaki T, Trenz K, Costanzo V, Petronczki M,. 2008. Polo-like kinase 1 reaches beyond mitosis-Cytokinesis, DNA damage response, and development. Curr Opin Cell Biol 20: 650-660.
35. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K,. 2013. Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer 49: 3020-3028.
36. van de Weerdt BC, Medema RH,. 2006. Polo-like kinases: A team in control of the division. Cell Cycle 5: 853-864.
37. Vithalani KK, Shoffner JD, De Lozanne A,. 1996. Isolation and characterization of a novel cytokinesis-deficient mutant in Dictyostelium discoideum. J Cell Biochem 62: 290-301.
38. Yamamoto Y, Matsuyama H, Kawauchi S, Matsumoto H, Nagao K, Ohmi C, Sakano S, Furuya T, Oga A, Naito K, Sasaki K,. 2006. Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer. Oncology 70: 231-237.
39. Zhang S, Hemmerich P, Grosse F,. 2007. Centrosomal localization of DNA damage checkpoint proteins. J Cell Biochem 101: 451-465.
40. Zhang B, Huang B, Guan H, Zhang SM, Xu QZ, He XP, Liu XD, Wang Y, Shang ZF, Zhou PK,. 2011. Proteomic profiling revealed the functional networks associated with mitotic catastrophe of HepG2 hepatoma cells induced by 6-bromine-5-hydroxy-4-methoxybenzaldehyde. Toxicol Appl Pharmacol 252: 307-317.
41. Zhang SM, Song M, Yang TY, Fan R, Liu XD, Zhou PK,. 2012. HIV-1 Tat impairs cell cycle control by targeting the Tip60, Plk1 and cyclin B1 ternary complex. Cell Cycle 11: 1217-1234.
42. Zhao C, Gong L, Li W, Chen L,. 2010. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 136: 9-16.
43. Zhou P,. 2011. DNA damage, signaling and repair: Protecting genomic integrity and reducing the risk of human disease. Chin Sci Bull 56: 3119-3121.